Drug Topics

MAY 22, 2023

Active tobacco use and BMI were inversely related to the risk of developing IPD.

465

465

PharmaVoice

MAY 22, 2023

The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients.

264

264

Drug Topics

MAY 22, 2023

The approval of Rinvoq (upadacitinib) was based on the results of three clinical trials: two induction therapy studies and one maintenance study.

FDA 460

FDA 460

PharmaVoice

MAY 22, 2023

How these consumer and service companies are tapping into major trends in the biopharma industry.

264

264

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PhRMA

MAY 22, 2023

As we’ve discussed on this blog before, the U.S. Food and Drug Administration’s (FDA) accelerated approval program has served as a critical lifeline for patients with serious and life-threatening conditions. The program was originally established at the urging of patient advocates during the height of the HIV/AIDS epidemic, in which patients waited years for the FDA to review and approve new treatments.

FDA 262

FDA 262

Drug Topics

MAY 22, 2023

According to commentaries published in the Annals of Internal Medicine, doctors remain split on the question.

247

247

Drug Topics

MAY 22, 2023

Exhaled carbon monoxide in vape users significantly decreased between their first and third clinical visits.

247

247

Pharmacy Times

MAY 22, 2023

Supportive nurse managers and supervisors as well as nurses’ involvement in organizational governance may help lower hospital-onset Clostridioides difficile infection in acute care hospitals.

Hospitals 132

Hospitals 132

Drug Topics

MAY 22, 2023

A higher dose of the carbonic anhydrase inhibitor does not seem to provide any additional improvements.

247

247

Pharmacy Times

MAY 22, 2023

OTC nicotine replacement products can come in a transdermal patch, nicotine gum, or lozenges.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

MAY 22, 2023

Some patients with PAH need to travel long distances, which may impact their access to quality care providers.

247

247

PharmaVoice

MAY 22, 2023

In Benjamin Moutier’s new role in haematology, he says he will focus on leading transformational changes that will pave the way to developing therapies and improving outcomes across a broad range of haematological diseases.

130

130

Pharmacy Times

MAY 22, 2023

Avapritinib has been FDA approved for the treatment of advanced systemic mastocytosis since June 2021.

FDA 129

FDA 129

STAT

MAY 22, 2023

BOSTON — Scientific journals have become something of a Mad Libs game for GPT: Artificial intelligence can now detect __, or speedily tell the difference between __ and __.  But which of these studies are actually important? How can clinicians sort them out from one another? At a recent AI conference, Atman Health chief medical officer and Brigham and Women’s associate physician Rahul Deo boiled the issue down in a single slide: the riskiest, most impactful studies draw far le

Hospitals 123

Hospitals 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 22, 2023

Beremagene geperpavec completely closed severe blistering and wounds in more than half of all patients with dystrophic epidermolysis bullosa with specific mutations.

FDA 123

FDA 123

Fierce Healthcare

MAY 22, 2023

Mayo Clinic, Johns Hopkins and 20 others pledge to join TEFCA, prioritize interoperability aburky Mon, 05/22/2023 - 17:13

Mayo Clinic 122

Mayo Clinic 122

Pharmacy Times

MAY 22, 2023

Many patients with post-COVID-19 condition reported perceived cognitive deficits early during their COVID-19 infection as well.

123

123

Fierce Healthcare

MAY 22, 2023

The feds still haven't reached a debt ceiling deal.

122

122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

MAY 22, 2023

The ongoing patent litigation between CureVac and Pfizer /BioNTech will move to a court in Virginia following a request from Curevac, potentially bringing forward the trial date to sometime in 2024. The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies.

Vaccines 116

Vaccines Communication 116

Fierce Pharma

MAY 22, 2023

Blueprint's Ayvakit picks up long-awaited FDA approval in indolent systemic mastocytosis zbecker Mon, 05/22/2023 - 14:43

FDA 113

FDA 113

Fierce Healthcare

MAY 22, 2023

Black veterans less able to manage chronic pain via telehealth services aburky Mon, 05/22/2023 - 14:58

111

111

PharmExec

MAY 22, 2023

The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.

111

111

STAT

MAY 22, 2023

In 2012, the United States Preventive Services Task Force convened to determine whether it should recommend kidney disease screening for all Americans. Advocates had been pushing for it, citing ballooning rates of chronic kidney disease. But at the time, the group found there wasn’t enough evidence to say if screening was a net good. That paradigm has since shifted, says Marika Cusick, a Ph.D. candidate in health policy at Stanford.

111

111

Pharmaceutical Technology

MAY 22, 2023

The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted an investigational new drug application (IND) for SinoMab BioScience’s SM17 to treat asthma. SM17 is a humanised IgG4-k monoclonal antibody that targets IL-17RB to treat asthma, idiopathic pulmonary fibrosis (IPF), atopic dermatitis (AD) and other immunological disorders.

Immunization 109

Immunization 109

STAT

MAY 22, 2023

I once saw a patient who came to the emergency room with injuries that were clearly related to domestic violence. Instead of offering a compassionate ear and a blanket to cover her exposed body after an assault, her intake nurse rushed through a checklist intended to screen her for social needs. While facing the computer screen, the nurse asked the patient a series of sensitive questions, including one about whether she had experienced domestic violence.

111

111

Fierce Healthcare

MAY 22, 2023

Texas AG investigating second children's hospital over gender-affirming care dmuoio Mon, 05/22/2023 - 12:46

Hospitals 105

Hospitals 105

Fierce Pharma

MAY 22, 2023

Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE zbecker Mon, 05/22/2023 - 10:44

102

102

STAT

MAY 22, 2023

The area of North Bellport on Long Island sits in the shadows of a massive landfill. This predominantly Black and Latino neighborhood also has the lowest life expectancy on Long Island, as well as the second-highest rates of asthma. Environmental activists do not think this is a coincidence, and for decades they have waged a battle to shut down the Brookhaven Landfill, which they believe is making their community sick.

102

102

Hospital Pharmacy Europe

MAY 22, 2023

Spironolactone is a cheap, safe and effective for treating women with acne that can also be used in the longer term, a large UK study has shown. The randomised controlled trial of 410 women over the age of 18 years with mild, moderate and severe acne found a significant difference in both in quality of life and self-reported acne improvement compared with placebo.

Hospitals 102

Hospitals 102

Fierce Pharma

MAY 22, 2023

Pfizer, Moderna among many biopharma giants to post Q1 sales declines, as Novo Nordisk led growth charge kdunleavy Mon, 05/22/2023 - 13:04

100

100

STAT

MAY 22, 2023

WASHINGTON — U.S. health regulators on Monday approved a new, easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis. Opvee is similar to  naloxone , the lifesaving drug that has been  used for decades to quickly counter overdoses of heroin, fentanyl, and prescription painkillers.

FDA 98

FDA 98

European Pharmaceutical Review

MAY 22, 2023

A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. While the counterfeit market is estimated to be a market of over $200 billion and despite its benefits, blockchain technology has not been fully implemented in the pharmaceutical supply chain, according to the paper.

98

98

STAT

MAY 22, 2023

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy , led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine. In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said

98

98